United States v. Fuhai Li

Court of Appeals for the Third Circuit·Decided July 9, 2020·No. 19-1875·Unpublished

Opinion

NOT PRECEDENTIAL

UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT

No. 19-1875

UNITED STATES OF AMERICA

v.

FUHAI LI,

Appellant

Appeal from the United States District Court for the Middle District of Pennsylvania (D.C. Criminal Action No. 3-16-cr-00194-001)

District Judge: Honorable A. Richard Caputo

Submitted Under Third Circuit L.A.R. 34.1(a)

April 14, 2020

Before: AMBRO, JORDAN and SHWARTZ, Circuit Judges (Opinion filed: July 9, 2020)

OPINION*

AMBRO, Circuit Judge

*

This disposition is not an opinion of the full Court and pursuant to I.O.P. 5.7 does not constitute binding precedent.

A jury convicted Fuhai Li, a doctor, for the unlawful distribution and dispensing of controlled substances, distribution to a pregnant woman, distribution resulting in death, maintaining drug-involved premises, money laundering, and tax evasion. Li appealed, alleging insufficiency of the evidence, improperly admitted evidence and expert testimony, and errors in the jury instructions and the calculation of forfeiture. As all the claims fail, we affirm Li’s convictions.

I. Factual and Procedural Background Li ran Neurology and Pain Management, a medical practice in Milford, Pennsylvania. He made prescription Schedule II narcotics easily available to those who sought them—persons in severe pain (who ultimately developed addictions), ongoing addicts, and those involved in the illegal resale of the controlled substances. By 2013 Li was one of the highest prescribers of oxycodone and other controlled substances in the Commonwealth.

Li generally required immediate cash payments for his visits. His patients paid $250 to $350 for an initial visit, and $150 for monthly visits thereafter. These visits were often brief and Li’s medical examinations superficial. Some patients testified that they received prescriptions for high dosages of oxycodone or other opioids without sharing their prior medical records or even their medical history. At follow-up visits, Li’s patients often simply asked for higher doses of narcotics, and he would write the prescription accordingly. He also continued to write scripts for patients who admitted to taking more pills than prescribed, and increased dosages even though patients reported

stable conditions. Li falsified his patients’ medical records, including medical exams that were never performed and billing health insurers for these tests.

Li’s conduct ultimately did not go unnoticed. His patients called his practice to complain when pharmacies stopped filling their prescriptions. Li’s receptionists directed them to specific pharmacies where Li had pre-existing relationships. At trial, Robert Welsh, a pharmacist, explained that Li’s patients exhibited “all [the] textbook flags that . . . you should not fill the prescription.” S.A. 272. Thus, abiding by his professional obligation not to fill what appeared to be unlawful prescriptions, he turned Li’s patients away. The testimony of other pharmacists corroborated his view. They noted that Li’s patients tended to present prescriptions for large quantities of pills at the maximum dosage, were unwilling to present photo identification, often traveled long distances to obtain the drugs, and preferred to pay in cash. Further, when these pharmacists attempted to verify prescriptions with Li’s office, they often faced roadblocks, such as the office’s refusal to provide a diagnosis for the prescription, reliance on the same diagnosis for many patients, or even being told “if you don’t want to fill it, don’t fill it.” S.A. 274.

Two of Li’s patients were key to the charges in this case: Rachel Scarpa and Suzanne Maack. Li began treating Ms. Scarpa for neck pain in January 2013. In March 2014 he wrote her a prescription for 120 30-milligram oxycodone pills after being warned twice by his staff that she was visibly pregnant. Per Li’s records, she had gained 40 pounds over eight months. At trial, Li testified that he just thought Ms. Scarpa had gotten fat. Eleven days later, she gave birth to a full-term, opioid-dependent baby.

Li treated Suzanne Maack for the first time two days before she died from an overdose of Oxycodone. Ms. Maack’s husband testified that Li’s initial exam of his wife was cursory and ignored all signs of her psychiatric disorders, drug addiction, and suicidal history. At the end of the appointment, Li wrote Ms. Maack a prescription for 120 15-milligram oxycodone pills. She overdosed and died after taking approximately 42 pills the next evening.

At trial, the jury also heard from Dr. Stephen Thomas, the Government’s expert.

He discussed the medical standards for pain management and the evidence of medically illegitimate prescribing practices found in each of the thirty-seven patient files he reviewed. He noted that Li failed to collect adequately new patients’ medical history, regularly prescribed the highest dosage of highly addictive opioid medication at the very first visit, failed to establish that there were medically legitimate reasons for those prescriptions, wrote prescriptions when faced with evidence of drug abuse and addiction disorders, and engaged in sexual activity and other sexually inappropriate conduct with at least three patients for whom he wrote prescriptions.

In January 2015 the Government seized approximately $1,030,960 in cash from Li’s townhouse in Milford and home in East Stroudsburg, PA, and $1,073,446 from his bank accounts. The IRS determined that his medical practice failed to report $832,980.45 in income between 2011 and 2013. Evidence showed Li, who was responsible for all aspects of his pain management business, provided his accountant with records of his patients’ medical histories, lab results, appointments, and payment histories that differed significantly from those in his “eClinical” software. Further, after the Government

conducted search warrants for Li’s records, he adjusted his 2014 taxes to reflect this additional income and asked his accountant to amend his returns from prior years.

After the Government concluded its case at trial, Li made an oral motion for a Judgment of Acquittal pursuant to Federal Rule of Criminal Procedure 29(a), asserting that there was insufficient evidence to show he committed any of the charged crimes, which the District Court denied. At the conclusion of the nineteen-day trial, the jury convicted Li of twenty-three counts of federal violations for unlawful distribution and dispensing of a controlled substance, unlawful distribution and dispensing of a controlled substance resulting in death, unlawful distribution and dispensing of a controlled substance to a pregnant individual, maintaining a drug-involved premises, money laundering, and tax evasion.1 After forfeiture proceedings before the jury, it returned a special verdict form finding that the cash seized from Li’s bank accounts and his home, totaling over $2 million, was forfeitable because the monies had a nexus to his drug- distribution convictions, drug premises convictions, and/or money laundering convictions.

The District Court sentenced Li to 330 months’ imprisonment, to be followed by a six-year term of supervised release, $3,000 in special assessments, and $5,177.80 in restitution. United States v. Li, No. 3:16-cr-00194-ARC, 2019 WL 1877561, at *1–2, 4 (M.D. Pa. Apr. 4, 2019). He appeals his convictions.

II. Discussion2

Li raises five issues on appeal. We consider each in turn.

i.

Li prescribed Ms. Maack oxycodone two days before she died of an overdose from taking 42 pills. Based on testimony regarding this event, the jury convicted Li of unlawful distribution and dispensing of a controlled substance under 21 U.S.C. § 841 and applied the “death enhancement” pursuant to § 841(b)(1)(C), which imposes a 20-year mandatory-minimum sentence. Li asserts that the trial evidence was insufficient to prove Ms. Maack’s prescription was outside the course of professional conduct. We disagree.

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Fuhai Li, (3d Cir. 2020).

United States v. Fuhai Li (United States v. Fuhai Li) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related